» Articles » PMID: 14755074

Regulation of Allergy and Autoimmunity in Helminth Infection

Overview
Date 2004 Feb 3
PMID 14755074
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Parasitic infections are a major theme in the "hygiene hypothesis", as allergies and autoimmune diseases are less prevalent in countries with higher burdens of helminths and other parasitic organisms. Helminths"-the grouping of multicellular worm parasites including nematodes, cestodes and trematodes-tend to establish long-lived, chronic infections indicating successful down-modulation of the host immune system. In this review, we describe the intricate immunology of host-helminth interactions and how parasites manipulate immune responses to enhance their survival. In so doing, they often minimise immunopathology and, it is suggested, reduce host susceptibility to, and severity of allergic and autoimmune diseases. Studies on helminth-infected communities and individuals support the hypothesis that an immuno-regulatory network promoted by parasites extends its influence to limiting allergies. Experimental models are now probing more deeply into the area of immune modulation by helminths, and we discuss the likely mechanisms by which helminths could be establishing a strongly regulatory environment. Understanding and harnessing the modulatory capacity of helminths may uncover novel therapeutic interventions, mimicking and exploiting their evolution for our benefit. Parasitic infections are a major theme in the "hygiene hypothesis", as allergies and autoimmune diseases are less prevalent in countries with higher burdens of helminths and other parasitic organisms. Helminths"-the grouping of multicellular worm parasites including nematodes, cestodes and trematodes-tend to establish long-lived, chronic infections indicating successful down-modulation of the host immune system. In this review, we describe the intricate immunology of host-helminth interactions and how parasites manipulate immune responses to enhance their survival. In so doing, they often minimise immunopathology and, it is suggested, reduce host susceptibility to, and severity of allergic and autoimmune diseases. Studies on helminth-infected communities and individuals support the hypothesis that an immuno-regulatory network promoted by parasites extends its influence to limiting allergies. Experimental models are now probing more deeply into the area of immune modulation by helminths, and we discuss the likely mechanisms by which helminths could be establishing a strongly regulatory environment. Understanding and harnessing the modulatory capacity of helminths may uncover novel therapeutic interventions, mimicking and exploiting their evolution for our benefit.

Citing Articles

Rural Embodiment and Community Health: an Anthropological Case Study on Biocultural Determinants of Tropical Disease Infection and Immune System Development in the USA.

Gildner T, Cepon-Robins T Curr Trop Med Rep. 2023; 10(1):26-39.

PMID: 36714157 PMC: 9868515. DOI: 10.1007/s40475-023-00282-z.


Helminth-virus interactions: determinants of coinfection outcomes.

Desai P, Diamond M, Thackray L Gut Microbes. 2021; 13(1):1961202.

PMID: 34428107 PMC: 8405156. DOI: 10.1080/19490976.2021.1961202.


-based helminth therapy in C3(1)-TAg mice does not alter breast tumor onset or progression.

Sauer S, Beinart D, Finn S, Kumar S, Cheng Q, Hwang S Evol Med Public Health. 2021; 9(1):131-138.

PMID: 33738103 PMC: 7953836. DOI: 10.1093/emph/eoab007.


Between a hygiene rock and a hygienic hard place: Avoiding SARS-CoV-2 while needing environmental exposures for immunity.

Parker W, Sarafian J, Broverman S, Laman J Evol Med Public Health. 2021; 9(1):120-130.

PMID: 33732461 PMC: 7928958. DOI: 10.1093/emph/eoab006.


Helminth infection modulates systemic pro-inflammatory cytokines and chemokines implicated in type 2 diabetes mellitus pathogenesis.

Rajamanickam A, Munisankar S, Dolla C, Menon P, Thiruvengadam K, Nutman T PLoS Negl Trop Dis. 2020; 14(3):e0008101.

PMID: 32126084 PMC: 7069638. DOI: 10.1371/journal.pntd.0008101.


References
1.
Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet L, Kemeny D . Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med. 2002; 8(6):625-9. DOI: 10.1038/nm0602-625. View

2.
Harvey H, Swords W, Apicella M . The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic neisseria and haemophilus. J Autoimmun. 2001; 16(3):257-62. DOI: 10.1006/jaut.2000.0477. View

3.
Williams C, Galli S . The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol. 2000; 105(5):847-59. DOI: 10.1067/mai.2000.106485. View

4.
Angeli V, Faveeuw C, Delerive P, Fontaine J, Barriera Y, Franchimont N . Schistosoma mansoni induces the synthesis of IL-6 in pulmonary microvascular endothelial cells: role of IL-6 in the control of lung eosinophilia during infection. Eur J Immunol. 2001; 31(9):2751-61. DOI: 10.1002/1521-4141(200109)31:9<2751::aid-immu2751>3.0.co;2-4. View

5.
Nakae S, Komiyama Y, Yokoyama H, Nambu A, Umeda M, Iwase M . IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int Immunol. 2003; 15(4):483-90. DOI: 10.1093/intimm/dxg054. View